Machine signal
Active cluster buy — 5 distinct insiders, $5M, window ends Aug 31, 2026.
Figures computed from official regulatory filings — .
Analysttarget 10.25 USD (+224%) · consensus 4.67/5 · 9 buy · 0 hold · 0 sell
Ownershipinsiders 9.65% · institutions 79.71% · short 3.2% of float
In USD · as of Oct 19, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Camp4 Therapeutics Corp only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-002 for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Market information source · Oct 19, 2026
SEC company identity · Oct 19, 2026
Open-market timeline · full history
23 buys6 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Gold Kelly | Buy | $39.6K | conv 83Cluster |
| SEC |
| Schwab Andrew J. | Sell | $1.6M | Unusual size | SEC |
| Schwab Andrew J. | Sell | $45 | SEC |
| Schwab Andrew J. | Sell | $214.9K | SEC |
| Schwab Andrew J. | Sell | $144.1K | SEC |
| Schwab Andrew J. | Sell | $520.7K | Unusual size | SEC |
| Tardiff Daniel | Sell | $8.3K | SEC |
| Gold Kelly | Buy | $10.8K | conv 54Cluster | SEC |
| 5AM Partners VI, LLC | BuyD (derivative) | $4.9M | ClusterFirst in 12mo | SEC |
| Maricich Yuri | Buy | $10.8K | conv 74Cluster | SEC |
| Schwab Andrew J. | AwardD (derivative) | $4.9M | SEC |
| Mandel-Brehm Josh | Buy | $10.8K | conv 52Cluster | SEC |
| YOUNG RICHARD A | Buy | $27K | conv 46Cluster | SEC |
| Stewart Murray | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| YOUNG RICHARD A | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Nashat Amirtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Holtzman Steven H | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| WILLIAMS DOUGLAS Etrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Schwab Andrew J. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| MacLean Michael F | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Maricich Yuri | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Mandel-Brehm Josh | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Tardiff Daniel | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Gold Kelly | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Mandel-Brehm Josh | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |